Related Experiment Video
Updated: Aug 17, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. stysia.romer@stjude.org
Abstract:
Medulloblastoma is the most common malignant pediatric brain tumor for which no satisfactory treatments exist. The Sonic Hedgehog signaling pathway seems to play an important role in the pathology of this disease. Here we review our recent demonstration that a small-molecule inhibitor of this pathway can regress tumors that arise in a transgenic mouse model of medulloblastoma. These and other findings suggest that inhibitors of Sonic Hedgehog signaling may offer an effective way to target some malignancies.
Insights
A new study shows that inhibiting the Sonic Hedgehog signaling pathway can shrink medulloblastoma tumors in mice. This finding offers hope for new treatments for this common pediatric brain cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Medulloblastoma is the most common malignant pediatric brain tumor.
- Current treatments for medulloblastoma are unsatisfactory.
- The Sonic Hedgehog (SHH) signaling pathway is implicated in medulloblastoma development.
Purpose of the Study:
- To investigate the therapeutic potential of targeting the Sonic Hedgehog pathway in medulloblastoma.
- To evaluate the efficacy of a small-molecule inhibitor of SHH signaling in a preclinical model.
Main Methods:
- Utilized a transgenic mouse model of medulloblastoma.
- Administered a small-molecule inhibitor targeting the Sonic Hedgehog pathway.
- Monitored tumor regression and assessed pathway activity.
Main Results:
- The small-molecule inhibitor effectively regressed medulloblastoma tumors in the mouse model.
- Inhibition of the Sonic Hedgehog pathway demonstrated significant anti-tumor activity.
- Successful targeting of the SHH pathway offers a potential therapeutic strategy.
Conclusions:
- Inhibitors of the Sonic Hedgehog signaling pathway show promise as a novel treatment for medulloblastoma.
- Targeting the SHH pathway may be an effective strategy for treating certain malignancies.
- Further research into SHH pathway inhibitors is warranted for pediatric brain tumors.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Mitogens and the Cell Cycle
Inhibition of Cdk Activity

